Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 317(2): 491-9, 2004 Apr 30.
Article in English | MEDLINE | ID: mdl-15063784

ABSTRACT

Congenital heart disease (CHD) is a major clinical manifestation of Down syndrome (DS). We recently showed that chimeric mice containing a human chromosome 21 (Chr 21) exhibited phenotypic traits of DS, including CHD. Our previous study showed that myosin light chain-2a (mlc2a) expression was reduced in the hearts of chimeric mice and DS patients. We found that phosphatidylethanolamine binding protein (PEBP) was also downregulated in Chr 21 chimeras in this study. As mlc2a is involved in heart morphogenesis, and PEBP controls the proliferation and differentiation of different cell types, these genes are candidates for involvement in DS-CHD. The DS-CHD candidate region has been suggested to span between PFKL and D21S3, which is the STS marker near the ETS2 loci. To identify gene(s) or a gene cluster on Chr 21 responsible for the downregulation of mlc2a and PEBP, we fragmented Chr 21 at the EST2 loci, by telomere-directed chromosome truncation in homologous recombination-proficient chicken DT40 cells. The modified Chr 21 was transferred to mouse ES cells by microcell-mediated chromosome transfer (MMCT), via CHO cells. We used ES cell lines retaining the Chr 21 truncated at the ETS2 locus (Chr 21E) to produce chimeric mice and compared overall protein expression patterns in hearts of the chimeras containing the intact and the fragmented Chr 21 by two-dimensional electrophoresis. While mouse mlc2a and PEBP expression was downregulated in the chimeras containing the intact Chr 21, the expression was not affected in the Chr 21E chimeras. Therefore, we suggest that Chr 21 gene(s) distal from the ETS2 locus reduce mouse mlc2a and PEBP expression in DS model mice and DS. Thus, this chromosome engineering technology is a useful tool for identification or mapping of genes that contribute to the DS phenotypes.


Subject(s)
Androgen-Binding Protein , Cardiac Myosins/genetics , Cardiac Myosins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Chromosomes, Human, Pair 21/genetics , Down Syndrome/genetics , Down Syndrome/metabolism , Myosin Light Chains/genetics , Myosin Light Chains/metabolism , Animals , Cell Line , Disease Models, Animal , Down-Regulation/genetics , Gene Expression Regulation , Heart Defects, Congenital/genetics , Heart Defects, Congenital/metabolism , Humans , Mice , Mutagenesis, Site-Directed , Myocardium/metabolism , Phosphatidylethanolamine Binding Protein , Phospholipid Transfer Proteins
2.
Biotechniques ; 36(3): 418-22, 424, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15038157

ABSTRACT

Fluorescent proteins (FPs) have revolutionized many aspects of cell biology and have become indispensable research tools. Today's increasingly complex experiments aiming to understand biological systems strongly depend on the availability of combinations of multiple FPs, which allow their distinguishable simultaneous detection in the same cell or tissue. Recently, the VENUS and DsRed. T4 FPs were described as the latest generation of yellow and red FPs. To increase the combinatorial possibilities when using these optimized FPs, we have generated and successfully tested seven new forms of VENUS and DsRed. T4 proteins with distinct subcellular localization. To facilitate their use as markers in biological experiments, bicistronic expression constructs, which have been optimized for robust expression in almost all mammalian developmental stages and cell types, were produced for the new FPs. In addition, several plasmids were created, which contain all necessary elements for inserting the reading frames of these FPs into specific gene loci in knock-in experiments without disrupting the reading frame of the endogenous gene.


Subject(s)
Cell Separation/methods , Flow Cytometry/methods , Fluorescent Antibody Technique/methods , Fluorescent Dyes/metabolism , Intracellular Space/metabolism , Luminescent Proteins/metabolism , Protein Engineering/methods , Cell Line , Humans , Kidney/metabolism , Luminescent Proteins/genetics , Recombinant Proteins/metabolism
3.
Genomics ; 81(6): 556-9, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12782124

ABSTRACT

We have previously established a series of human monochromosomal hybrids containing a single human chromosome of defined parental origin as an in vitro resource for the investigation of human imprinted loci. Using the hybrids with a paternal or maternal human chromosome 7, we determined the allelic expression profiles of 76 ESTs mapped to the human chromosome 7q21-q31. Seven genes/transcripts, including PEG10 which has previously been reported to be imprinted, showed parent-of-origin-specific expression in monochromosomal hybrids. One of the 6 candidate genes/transcripts, i.e., DLX5 was confirmed to be imprinted in normal human lymphoblasts and brain tissues by a polymorphic analysis. Thus, an imprinted domain has been newly defined in the region of human chromosome 7q21-q31 using human-mouse monochromosomal hybrids.


Subject(s)
Chromosomes, Human, Pair 7/genetics , Genomic Imprinting/genetics , Homeodomain Proteins/genetics , Multigene Family/genetics , Animals , Apoptosis Regulatory Proteins , Brain/metabolism , Chimera , DNA-Binding Proteins , Expressed Sequence Tags , Humans , Lymphocytes/metabolism , Mice/genetics , Proteins/genetics , RNA-Binding Proteins , Transcription Factors
4.
J Hum Genet ; 48(4): 208-11, 2003.
Article in English | MEDLINE | ID: mdl-12730726

ABSTRACT

Expressed sequence tags (ESTs) in the human chromosome 7q21-q31 region were recently used to screen for allelic expression bias in monochromosomal hybrids retaining a paternal or maternal human chromosome 7. Six candidate imprinted genes were identified. In this study, we investigated parent-of-origin-specific expression profiles of their mouse homologues in the proximal region of chromosome 6. An imprinting analysis, using F1 mice from reciprocal crosses between the B6 and JF strains, demonstrated that the mouse calcitonin receptor gene ( Calcr) was expressed preferentially from the maternal allele in brain, whereas no allelic bias was detected in other tissues. Our results indicate that Calcr is imprinted in a tissue-specific manner, with a predominant expression from the maternal allele in the brain.


Subject(s)
Brain/metabolism , Chromosomes, Mammalian/genetics , Genomic Imprinting/genetics , Physical Chromosome Mapping , Receptors, Calcitonin/genetics , Animals , Gene Expression Profiling , Mice , Organ Specificity , RNA, Messenger/genetics , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...